Entrada Therapeutics, Inc. (TRDA) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$143.75M | -319.0% |
| 2024 | $65.63M | +1081.7% |
| 2023 | -$6.68M | +92.9% |
| 2022 | -$94.62M | -84.9% |
| 2021 | -$51.16M | -92.9% |
| 2020 | -$26.52M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$143.75M | -319.0% |
| 2024 | $65.63M | +1081.7% |
| 2023 | -$6.68M | +92.9% |
| 2022 | -$94.62M | -84.9% |
| 2021 | -$51.16M | -92.9% |
| 2020 | -$26.52M | — |